Leo is leaning over the laminated wood of the pharmacy counter, his fingers tracing the jagged edge of a taped-down flyer for flu shots. He is currently into an explanation he has given in the last calendar year.
His voice is steady-a practiced, artificial calm that masks the fact that his T-cell count is currently a mathematical insult to his longevity. He is explaining to a pharmacist, who looks like she hasn’t slept since , why a three-day delay in his Nitazoxanide prescription isn’t a logistical “hiccup” but a trapdoor.
Audit in Progress
Leo’s 16th repetitive explanation this year.
He doesn’t want to be the guy who makes a scene. He’s not a “Karen,” and he’s not looking for a manager. He’s looking for the 500 mg tablets that stand between him and a localized systemic collapse. But the system is built on the assumption that everyone has a “next week.”
The Involuntary Auditor
This is the hidden reality of being an involuntary auditor of the American healthcare system. When your body functions on a razor’s edge, you notice every nick in the blade. You see the gaps in the supply chain, the administrative friction that generates heat but no light, and the way the “cost-benefit analysis” usually forgets to account for the human being at the end of the spreadsheet.
I spent three hours last night trying to explain cryptocurrency to my cousin, and I realized halfway through that the blockchain is surprisingly similar to a hospital billing department. It’s a distributed ledger of pain where nobody actually knows who owns the original “coin” of your health, but everyone is very certain about the transaction fees.
Blockchain
Distributed Ledger
Billing Dept.
Transaction Fees
The decentralized mess of insurers and physical survival.
You’re navigating a decentralized mess of insurers, PBMs, and manufacturers, all while trying to make sure your own personal “wallet”-your physical body-doesn’t get emptied by a rogue infection. It’s a high-stakes game of “gas fees” where the gas is your literal breath.
Simon K.L., a therapy animal trainer I know, sees this divergence every day. Simon works primarily with service dogs trained for “invisible” disabilities-seizure detection, glucose sensing, and severe immune responses. He’s a man who speaks in the cadence of someone who has spent more time with Labradors than lobbyists.
He told me once, over a lukewarm cup of coffee that cost $6, that his dogs are better auditors of health than most diagnostic codes.
“A dog doesn’t care about the Prior Authorization. The dog smells the cortisol. The dog feels the shift in the skin temperature. The dog reacts to the reality of the body. The system, though? The system reacts to the reality of the contract.”
– Simon K.L., Service Dog Trainer
“I’ve seen this month who are more afraid of their insurance company than they are of their actual disease. That’s a design flaw that we’ve mistaken for a standard operating procedure.”
Simon’s perspective is colored by the fact that he sees the “pre-symptomatic” world. He sees the before the crisis. He understands that for the immunocompromised, healthcare isn’t a destination you visit when you’re sick; it’s a structural environment you never leave.
When you live with a condition that turns an everyday microbe into a clinical emergency, you become acutely aware that the medications preventing the emergency often cost more than the emergency room visit you’re trying to avoid. It is a bizarre, inverted math.
A single course of specialized anti-parasitics or antivirals can run into the hundreds, sometimes thousands. You find yourself staring at a screen, typing
why is nitazoxanide so expensive
into a search bar at , wondering why the price of a molecule discovered decades ago has suddenly spiked to the level of a used car.
Molecule vs. Used Car
When generic molecules reach parity with mechanical assets.
The Loop of Silence
The system isn’t failing by accident; it’s failing because the people who notice the failures are the ones with the least amount of leverage to fix them. If you’re healthy, the “brokenness” of a pharmacy queue is a nuisance. If you’re immunocompromised, that same queue is a gauntlet.
You are the one who notices that the “discount card” only works on the third Tuesday of the month, or that the generic version of your life-saving pill has been “backordered” for with no projected restock date.
The feedback loop is broken. The “auditors”-the patients-send their reports in the form of frantic phone calls, tearful pleas at the counter, and meticulously documented appeals. But those reports go into a void. They don’t reach the people who set the prices or the legislators who write the regulations.
I’ve made mistakes in my own life-big ones. I once thought that if you worked hard enough and “played by the rules,” the safety net would be there to catch you. I believed that “efficiency” in business was always a good thing.
But the immunocompromised community teaches you that “efficiency” is often just a code word for “cutting out the margins for error.” And when you are the margin for error, being cut out feels a lot like being erased.
The price is the price, but the cost is who you have to become to pay it.
Simon K.L. once told me about a client of his, a woman with a severe primary immunodeficiency. She had spent of the last year just managing her own care. Not being sick-just managing the care.
Calling the doctor, calling the insurer, calling the specialty pharmacy, driving to the one lab that takes her specific insurance, and then doing it all again the next week because a form was filed with the wrong middle initial.
“She’s a project manager for a company that is actively trying to fire her. That company is her own survival.”
– Simon K.L.
Survival Economics
There’s a specific kind of exhaustion that comes from having to prove your own vulnerability over and over again. To get the refill, you have to prove you’re still sick. To get the price break, you have to prove you’re still poor. To get the dignity of a conversation without being treated like a “problem customer,” you have to prove you’re worth the pharmacist’s time.
A system that has decided some lives are too expensive to be “efficient.”
It’s an audit of the soul. We look at the $836 price tag on a box of pills and we try to rationalize it. We talk about R&D costs and market dynamics. But the immunocompromised patient looks at that price and sees a “Keep Out” sign. They see a system that has decided some lives are too expensive to be “efficient.”
There’s a counterintuitive strength in this, though. A “yes, and” of the spirit. Yes, the system is a labyrinth of cruelty, AND those who navigate it develop a type of intelligence that is almost supernatural. They become experts in pharmacology, insurance law, and the subtle art of the “strategic kindness” that gets a clerk to look a little harder in the back room for that missing bottle of Alinia.
We talk about “healthcare reform” as if it’s a matter of moving blocks on a chart. We argue about “access” as if it’s just a doorway. But for the person waiting at the counter, access is a moving target.
It’s a 56-page document that needs to be signed by a doctor who is currently on vacation. It’s a copay that just jumped by $106 because the “tier” changed overnight.
Simon K.L.’s dogs don’t care about tiers. They don’t care about the price of Nitazoxanide. They only care about the human at the other end of the leash.
There is a profound lesson in that-a reminder that healthcare was supposed to be a human-to-human interaction, not a human-to-algorithm negotiation.
The Witness
As I watch Leo finally get his paper bag-the one with the stapled receipt that lists a “savings” of $436 that he’ll never actually see in his bank account-I realize that he isn’t just a patient. He is a witness. He is seeing the truth of our social contract: that it’s held together by the sheer willpower of the people it’s trying to exclude.
He walks out the door, the this year, and for a moment, the system looks exactly like what it is: a giant, humming machine that forgot it was built to serve the people inside it. He doesn’t ask for his of dignity back. He doesn’t have the time.
He has to go home and take his first dose, because “next week” is a mountain he still has to climb.
The audit is over for today. But tomorrow, the ledger will open again, and the immunocompromised will be there, pens ready, documenting every break in the line, waiting for the rest of us to finally look at the report.